Benign Prostatic Hyperplasia Pipeline Highlights - 2018

  • ID: 4516340
  • Report
  • Fore Pharma
1 of 3
The latest report Benign Prostatic Hyperplasia Pipeline Highlights - 2018, provides most up-to-date information on key pipeline products in the global Benign Prostatic Hyperplasia market. It covers emerging therapies for Benign Prostatic Hyperplasia in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Benign Prostatic Hyperplasia pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Benign Prostatic Hyperplasia pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Benign Prostatic Hyperplasia pipeline products by the company.

Short-term Launch Highlights:
Find out which Benign Prostatic Hyperplasia pipeline products will be launched in the US and Ex-US till 2020.

SUMMARY:
  • Benign Prostatic Hyperplasia phase 3 clinical trial pipeline products
  • Benign Prostatic Hyperplasia phase 2 clinical trial pipeline products
  • Benign Prostatic Hyperplasia phase 1 clinical trial pipeline products
  • Benign Prostatic Hyperplasia preclinical research pipeline products
  • Benign Prostatic Hyperplasia discovery stage pipeline products
  • Benign Prostatic Hyperplasia pipeline products short-term launch highlights
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Benign Prostatic Hyperplasia Pipeline by Stages
2. Benign Prostatic Hyperplasia Pipeline by Drug Class
3. Benign Prostatic Hyperplasia Pipeline by Company
4. Benign Prostatic Hyperplasia Phase 3 Clinical Trial Insights
5. Benign Prostatic Hyperplasia Phase 2 Clinical Trial Insights
6. Benign Prostatic Hyperplasia Phase 1 Clinical Trial Insights
7. Benign Prostatic Hyperplasia Preclinical Research Insights
8. Benign Prostatic Hyperplasia Discovery Stage Insights
9. Appendix
10. Research Methodology

List of Tables
Table 1: Benign Prostatic Hyperplasia Phase 3 Clinical Trials, 2018
Table 2: Benign Prostatic Hyperplasia Phase 2 Clinical Trials, 2018
Table 3: Benign Prostatic Hyperplasia Phase 1 Clinical Trials, 2018
Table 4: Benign Prostatic Hyperplasia Preclinical Research, 2018
Table 5: Benign Prostatic Hyperplasia Discovery Stage, 2018

List of Figures
Figures 1: Benign Prostatic Hyperplasia Pipeline Molecules by Clinical Trials Stage, 2018
Figure 2: Benign Prostatic Hyperplasia Pipeline Molecules by Drug Class, 2018
Figure 3: Benign Prostatic Hyperplasia Pipeline Molecules by Company, 2018
Figure 4: Benign Prostatic Hyperplasia Phase 3 Clinical Trial Highlights, 2018
Figure 5: Benign Prostatic Hyperplasia Phase 2 Clinical Trial Highlights, 2018
Figure 6: Benign Prostatic Hyperplasia Phase 1 Clinical Trial Highlights, 2018
Figure 7: Benign Prostatic Hyperplasia Preclinical Research Highlights, 2018
Figure 8: Benign Prostatic Hyperplasia Discovery Stage Highlights, 2018
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll